IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.

about

Liposome-targeted delivery for highly potent drugs.Engineering liposomal nanoparticles for targeted gene therapy.Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.

P2860

Q39171223-97A1A61E-1BD7-4188-AA6F-0B5C6E538367 Q39306702-06BC736A-22CC-4882-9DE3-C7943C8793EA Q49871522-23071569-5568-4E8F-98AD-3CE93E74F0AB

P2860

IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.

Item

http://www.wikidata.org/entity/Q48941494

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@en

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@nl

type

Item

label

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@en

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@nl

prefLabel

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@en

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@nl

P1476

IL-4Rα aptamer-liposome-CpG ol ...... g the tumour microenvironment.

@en

P2093

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Gui-Li Xu

http://www.w3.org/2001/XMLSchema#string

Hai-Feng Song

http://www.w3.org/2001/XMLSchema#string

Jie Fu

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Shen-Si Xiang

http://www.w3.org/2001/XMLSchema#string

Xiao-Lin Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Qian Dou

http://www.w3.org/2001/XMLSchema#string

Xin Gao

http://www.w3.org/2001/XMLSchema#string

Yu-Jie Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications

Myeloid-derived suppressor cells as regulators of the immune system

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice.

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models

Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells

The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

P304

275-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1061186X.2016.1258569

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27819142

http://www.w3.org/2001/XMLSchema#string

IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.

about

P2860

P2860

IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698